Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Leptin | 1 | ng/mL | 3 | LIF | 133.0 | 51 | ||||
N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | LIF | 157.5 | 68 | |
N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | LIF | 110.0 | 59 | |
N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | LIF | 140.5 | 46 | |
N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | LIF | 114.0 | 70 | |
N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | LIF | 114.0 | 74 | |
RA2159 | Adiponectin | 5 | ng/mL | 3 | LIF | 124.0 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 129.0 | 46 | |
RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 151.0 | 72 | |
RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 109.0 | 45 | |
RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 130.0 | 65 | |
RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 128.0 | 59 | |
N2586 | Adiponectin | 5 | ng/mL | 3 | LIF | 187.0 | 54 | ||||
N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 155.0 | 71 | |
N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 139.0 | 73 | |
N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 148.0 | 45 | |
N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 128.5 | 38 | |
N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | LIF | 173.5 | 70 | |
RA2159 | IGF-I | 100 | ug/mL | 3 | LIF | 96.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 105.0 | 79 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 110.0 | 52 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 91.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 79.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | LIF | 79.5 | 44 | |
RA2159 | 3 | LIF | 76.5 | 66 |